BONH
IBB icon

Bank of New Hampshire’s iShares Biotechnology ETF IBB Stock Holding History

Bank of New Hampshire’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$325K Sell
1,542
-225
-13% -$45.1K 0.07% 169
2026
Q2 		$336K Sell
1,767
-165
-9% -$28.4K 0.07% 168
2026
Q1 		$326K Hold
1,932
– – 0.07% 158
2025
Q4 		$326K Sell
1,932
-125
-6% -$20.3K 0.07% 161
2025
Q3 		$297K Sell
2,057
-7
-0.3% -$955 0.07% 161
2025
Q2 		$261K Sell
2,064
-460
-18% -$56.5K 0.06% 164
2025
Q1 		$323K Sell
2,524
-188
-7% -$25.5K 0.08% 155
2024
Q4 		$359K Sell
2,712
-172
-6% -$24.2K 0.09% 149
2024
Q3 		$420K Sell
2,884
-248
-8% -$35.9K 0.11% 145
2024
Q2 		$430K Sell
3,132
-350
-10% -$46.7K 0.11% 139
2024
Q1 		$478K Sell
3,482
-125
-3% -$17.1K 0.13% 134
2023
Q4 		$490K Sell
3,607
-914
-20% -$112K 0.14% 132
2023
Q3 		$553K Sell
4,521
-342
-7% -$43.5K 0.17% 124
2023
Q2 		$617K Sell
4,863
-143
-3% -$18.6K 0.18% 118
2023
Q1 		$647K Sell
5,006
-574
-10% -$75.1K 0.19% 111
2022
Q4 		$733K Sell
5,580
-600
-10% -$77.5K 0.22% 107
2022
Q3 		$723K Sell
6,180
-643
-9% -$79.8K 0.23% 106
2022
Q2 		$803K Sell
6,823
-5,489
-45% -$652K 0.23% 106
2022
Q1 		$1.6M Sell
12,312
-335
-3% -$43.6K 0.39% 68
2021
Q4 		$1.93M Sell
12,647
-1,696
-12% -$263K 0.47% 63
2021
Q3 		$2.35M Hold
14,343
– – 0.63% 52
2021
Q2 		$2.35M Buy
+14,343
New +$2.21M 0.63% 52

Other funds holding IBB

AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
CCA
Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
KIG
Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return

Bank of New Hampshire's IBB Position: Q3 2026 in Review

Bank of New Hampshire reduced its iShares Biotechnology ETF (IBB) stake by 13% in Q3 2026, selling an estimated $45.1K and leaving 1,542 shares worth $325K. The position accounts for 0.07% of the portfolio, ranked #169.

Bank of New Hampshire first reported a position in IBB in Q2 2021 and has held it in 22 quarters since. The position peaked at $2.35M in Q3 2021. 38 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Bank of New Hampshire held 1,542 shares of iShares Biotechnology ETF worth $325K as of Q3 2026.
  • Bank of New Hampshire sold 225 iShares Biotechnology ETF shares in Q3 2026, an estimated $45.1K.
  • iShares Biotechnology ETF made up 0.07% of Bank of New Hampshire's portfolio in Q3 2026, its #169 holding.
  • Bank of New Hampshire first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 22 quarters since.
  • Bank of New Hampshire's iShares Biotechnology ETF position peaked at $2.35M in Q3 2021.
  • 38 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Bank of New Hampshire's 13F filing for Q3 2026, filed 6 Oct 2026.